This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Ctc Bio, Inc.. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Innovations of Jung-Hwa Kim in Pharmaceutical Formulations
Introduction
Jung-Hwa Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications that enhance stability and efficacy.
Latest Patents
Jung-Hwa Kim holds two patents, with his latest invention focusing on a pharmaceutical composition that includes clomipramine and sildenafil. This formulation aims to improve the stability of clomipramine, a medication commonly used for treating various mental health conditions. The invention details a method for manufacturing this pharmaceutical formulation using a wet granulation method, ensuring that both active ingredients are effectively combined to enhance their therapeutic properties.
Career Highlights
Jung-Hwa Kim is associated with Ctc Bio, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing formulations that address specific medical needs, thereby contributing to advancements in healthcare.
Collaborations
Jung-Hwa Kim collaborates with talented individuals in his field, including Hong Ryeol Jeon and Bong-Sang Lee. These partnerships foster a creative environment that enhances the development of innovative pharmaceutical solutions.
Conclusion
Jung-Hwa Kim's contributions to pharmaceutical formulations demonstrate his dedication to improving medication stability and efficacy. His innovative work continues to impact the healthcare industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile